Clinical trial for Atrial Fibrillation
Official title Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF
ClinicalTrials.gov ID: NCT05510167
What this study is testing
- What it's testing
- This study aims to find out if continuing to drink alcohol at previous levels after surgery leads to better or worse outcomes compared to reducing intake.
- Who it's for
- People who have atrial fibrillation and have recently had a catheter ablation procedure.
- What's involved
- Participants will be randomly assigned to either continue their usual alcohol intake or reduce it, and researchers will track their heart rhythm, quality of life, and thinking skills.
- Time commitment
- The source text does not specify the total duration or the number of required visits.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- AF patients that regularly consume \>5 alcoholic drink (\ 12 g of pure alcohol/drink)/week
- Paroxysmal or persistent AF
- First catheter ablation History of alcohol-induced arrhythmia
- Willing to sign the written informed consent
You likely can't join if
- Binge drinkers (alcohol dependence)
- Non-drinkers
- LVEF \<35%
- Psychiatric conditions
- MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA)
- Patients with established dementia
See the full eligibility criteria
- AF patients that regularly consume \>5 alcoholic drink (\ 12 g of pure alcohol/drink)/week
- Paroxysmal or persistent AF
- First catheter ablation History of alcohol-induced arrhythmia
- Willing to sign the written informed consent
- Binge drinkers (alcohol dependence)
- Non-drinkers
- LVEF \<35%
- Psychiatric conditions
- MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA)
- Patients with established dementia
- Medically unstable patients (acute/unstable or poorly controlled problems that would demand focused, relatively urgent or emergent medical attention)
- Unwilling for alcohol-abstinence
- Long-standing persistence AF
- Patient under legal protection
- Pregnancy
The study team makes the final eligibility decision.
Where it is enrolling
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Austin, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.